glp-1 select trial GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction GLP-1 Receptor Agonists as Treatments

G., Horowitz, M

Remember how our mums never stopped nagging us to eat our greens

MMA further contributes to oxidative stress by impairing the mitochondrial respiratory chain complexes and energy metabolism

GLP-1 therapies have rapidly become top drivers of drug spend

Most studies on muscle preservation during caloric restriction support a target of 1.2 to 1.6 grams of protein per kilogram of body weight per day and some researchers recommend up to 2.0 grams for older adults or those doing resistance training

High-strength capsule products require serious attention to consistency, manufacturing standards, and documentation review